Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation

スポンサーリンク

概要

• 論文の詳細を見る
• 2011-12-01

著者

• MARUTA Atsuo

  Department of Hematology, Kanagawa Cancer Center

• Takahashi Masatomo

  聖マリアンナ医科大学 血液･腫瘍内科

• 谷脇 雅文

  Department Of Environmental Systems Engineering Kochi University Of Technology

• FUJISAWA Shin

  Yokohama City University Medical Center

• Tanaka Masatsugu

  Department Of Hematology Kanagawa Cancer Center

• Tanimoto Mitsune

  Okayama Univ. Hospital Okayama Jpn

• Tanimoto Mitsune

  岡山大学 医歯総研究 第2内科

• Takahashi Masatomo

  St. Marianna Univ. School Of Medicine Kawasaki Jpn

• Tanimoto Mitsune

  名古屋大学 第1内科

• Kanamori Heiwa

  Department Of Hematology Kanagawa Cancer Center

• Kanamori Heiwa

  Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of

• Tsuji Takashi

  Department Of Hematology Kanagawa Cancer Center

• Ishigatsubo Yoshiaki

  Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of

• Maruta Atsuo

  Department Of Hematology Kanagawa Cancer Center

• Maruta A

  Kanagawa Cancer Center Yokohama City Jpn

• TAKASAKI Hirotaka

  Department of Hematology, Kanagawa Cancer Center

• Takasaki Hirotaka

  Department Of Hematology Kanagawa Cancer Center

• Mohri H

  The First Department Of Internal Medicine Yokohama City University School Of Medicine

• Tachibana Takayoshi

  Department Of Hematology Kanagawa Cancer Center

• Tachibana Takayoshi

  Department Of Hematology Shizuoka Red Cross Hospital

• Fujisawa Shin

  Department Of Hematology Yokohama City University Medical Center

• Kuwabara Hideyuki

  Department Of Hematology Kanagawa Cancer Center

• Ishigatsubo Yoshiaki

  Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of

• Tabata Masahiro

  The Department Of Internal Medicine Ii Okayama University Medical School

• NUMATA Ayumi

  Department of Hematology, Kanagawa Cancer Center

• Harada Hiroshi

  Department Of Electrical Engineering Osaka University

• Harada Hiroshi

  Department Of Hematology Showa University Fujigaoka Hospital

• Numata Ayumi

  Department Of Hematology Kanagawa Cancer Center

• MORI Hiraku

  Department of Hematology, Showa University Fujigaoka Hospital

• TSUJI Takashi

  Department of Hematology, Kanagawa Cancer Center

• HARADA HIROSHI

  Department of Anatomy, Kurume University School of Medicine

関連論文

• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
• 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
• In vivo Retrovirus-mediated Herpes Simplex Virus Thymidine Kinase Gene Therapy Approach for Adult T Cell Leukemia in a Rat Model
• Serum Levels of Soluble Fas/APO-1 Receptor in Human Retroviral Infection and Associated Diseases
• 点欠陥の自己組織化的挙動を利用した微細構造形成法
• イオン照射で導入される点欠陥を利用したナノセル構造の形成
• イオン照射によって導入された点欠陥によるセル構造の形成
• イオン照射による半導体微細セル構造の自己組織化形成
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Surface Sink Effects on Void Formation in GaSb and InSb under Ion Irradiation
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• Progressive osteosclerosis and visceral calcification after cord blood transplantation
• Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
• Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
• No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
• Case-control study of leukemia and diagnostic radiation exposure
• Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
• Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
• Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
• Successful cord blood transplantation for mycosis fungoides.
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Human T cell leukemia virus type-1 Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-kB pathway
• Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
• Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
• Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
• Pregnancy among long-term survivors of acute leukemia. A second nationwide survey
• The effect of adding rituximab to CHOP-based therapy on clinical outcomes for Japanese patients with diffuse large B-cell lymphoma : a propensity score matching analysis
• Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
• Double mutations of the N-ras gene in a patient with acute myelomonocytic leukemia
• Neurofibromatosis 1 gene (NF1) mutation is a rare genetic event in myelodysplastic syndrome regardless of the disease progression
• In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi-scid/scid Mice
• Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
• Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
• Morphological Diagnoses of the Japan Adult Leukemia Study Group Acute Myeloid Leukemia Protocols: Central Review
• Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
• Successful Treatment With a Chimeric Anti-CD20 Monoclonal Antibody (IDEC-C2B8, Rituximab) for a Patient With Relapsed Mantle Cell Lymphoma Who Developed a Human Anti-Chimeric Antibody
• Systemic Mastocytosis with Extensive Polypoid Lesions in the Intestines; Successful Treatment with Interferon-α
• Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
• Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein : a novel in vitro model of the growth of acute ATL cells
• Possible Involvement of Interferon Regulatory Factor 4 (IRF4) in a Clinical Subtype of Adult T-Cell Leukemia
• Recovery of Hematopoietic Progenitor Cells in Patients With Severe Aplastic Anemia Who Obtained Good Clinical Response With a Combination Therapy of Immunosuppressive Agents and Recombinant Human Granulocyte Colony-Stimulating Factor
• Kaposi's sarcoma - associated herpesvirus-like DNA sequences are not present in adult T-cell leukemia
• A Phase II Study of VEPA/FEPP Chemotherapy for Aggressive Lymphoma in Elderly Patients : Japan Clinical Oncology Group Study JCOG9203
• A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
• Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
• Deoxycoformycin-Containing Combination Chemotherapy for Adult T-Cell Leukemia-Lymphoma : Japan Clinical Oncology Group Study (JCOG9109)
• Possible Attenuation of Fas-Mediated Signaling by Dominant Expression of Caspase-8 Aberrant Isoform in Adult T-Cell Leukemia Cells
• The presence of mature granulocytes/monocytes derived from leukemic cells in MLL-associated leukemia
• A Novel Plasmacytoid Dendritic Cell Line, CAL-1, Established from a Patient with Blastic Natural Killer Cell Lymphoma
• Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
• Clinical Relevance of Survivin as a Biomarker in Neoplasms, Especially in Adult T-Cell Leukemias and Acute Leukemias
• Real-Time Polymerase Chain Reaction for Quantification of HTLV-1 Proviral Load: Application for Analyzing Aberrant Integration of the Proviral DNA in Adult T-Cell Leukemia
• Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Use of micafungin versus fluconazole for antifungal prophylaxis in neutropenic patients receiving hematopoietic stem cell transplantation
• Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome
• Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin
• Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia
• Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells
• Anti-AnWj antibody in a case with non-Hodgkin lymphoma
• Dexamethasone Reduces the Risk of Bortezomib-Induced Pulmonary Complications in Japanese Myeloma Patients
• Relapse of idiopathic thrombocytopenic purpura caused by influenza A virus infection : a case report
• Clinicopathologic and Cytogenetic Analyses of Three Cases of Primary Uterine Non-Hodgkin's Lymphoma
• 白滝鉱山が地域にもたらしたもの
• 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
• Formation of Anomalous Defect Structure on GaSb Surface by Low Temperature Sn Ion-Implantation
• 小特集の企画にあたって
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Recombinant adeno-associated virus-mediated gene transfer into human leukemia cell lines
• Detection of NOTCH1 Mutations in Adult T-Cell Leukemia/Lymphoma and Peripheral T-Cell Lymphoma
• Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia
• Scrotal Ulcers Arising during Treatment with All-trans Retinoic Acid for Acute Promyelocytic Leukemia
• Protein Expression and Constitutive Phosphorylation of Hematopoietic Transcription Factors PU.1 and C/EBPβ in Acute Myeloid Leukemia Blasts
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
• A Novel Human Multiple Myeloma-Derived Cell Line, NCU-MM-1, Carrying t(2;11)(p11;q23) and t(8;22)(q24;q11) Chromosomal Translocations With Overexpression of c-Myc Protein
• Acute myeloid leukemia in the elderly : 159 Nagoya case studies
• Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
• No Significant Association Between HA-1 Incompatibility and Incidence of Acute Graft-Versus-Host Disease After HLA-Identical Sibling Bone Marrow Transplantation in Japanese Patients
• CD4- and CD56-positive T-cell line MTA, established from natural killer-like T-cell leukemia/lymphoma
• Renal vein lymphoma embolism in non-Hodgkin lymphoma
• Allogeneic peripheral blood progenitor cell transplantation conditioned with anti-thymocyte globulin for treatment of graft failure after allogeneic bone marrow transplantation
• Successful treatment of a Jehovah's Witness with Acute promyleocytic leukemia
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
• Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase : results from the Japanese subgroup of ENESTnd
• Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies
• Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
• Prognostic factors in patients aged 50 years or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancy

もっと見る 閉じる

スポンサーリンク